| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0197-0186(94)00104-3 |
| P8608 | Fatcat ID | release_sot6loyimjg2xaol3wz3oejbti |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0197018694001043?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0197018694001043?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 7599530 |
| P2093 | author name string | D. B. Campbell | |
| P2860 | cites work | Metabolism of fenfluramine to norfenfluramine in guinea-pigs | Q34040026 |
| What is an appropriate measure of exposure when testing drugs for carcinogenicity in rodents? | Q35897498 | ||
| Man versus beast: pharmacokinetic scaling in mammals | Q38705508 | ||
| Comparison of the time course of the anorectic effect of fenfluramine and amphetamine with drug levels in blood | Q40327245 | ||
| The current status of attempts to predict species differences in drug metabolism | Q40327829 | ||
| Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine | Q41197417 | ||
| Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism | Q43205021 | ||
| Fluoxetine and trifluoperazine in human brain: a 19F-nuclear magnetic resonance spectroscopy study | Q43597505 | ||
| Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction | Q43758388 | ||
| Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs | Q43864916 | ||
| Pharmacokinetics and brain entry of alaptide, a novel nootropic agent, in mice, rats and rabbits | Q44256898 | ||
| Saturable transport of amphetamine across the blood-brain barrier | Q44410782 | ||
| Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine | Q45025381 | ||
| In-vivo (+)-[3H]fenfluramine binding to rat brain: biochemical and autoradiographic studies | Q45478577 | ||
| A Comparative Study of the Pharmacokinetics of Amphetamine | Q47899189 | ||
| Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration | Q48414122 | ||
| The effect of previous d-amphetamine treatment on the disposition and lethality of fenfluramine in the rat. | Q48478308 | ||
| Nonlinear Tissue Disposition: Salicylic Acid in Rat Brain | Q48487871 | ||
| Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain | Q48500625 | ||
| A new method for determining allowable daily intakes. | Q52687390 | ||
| Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. | Q52722509 | ||
| Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism | Q60678421 | ||
| Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in mouse, rat, dog and man | Q68000848 | ||
| In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector | Q69933538 | ||
| Study of human urinary metabolism of fenfluramine using gas chromatography-mass spectrometry | Q70146945 | ||
| Regulatory history and experimental support of uncertainty (safety) factors | Q70295952 | ||
| Kinetics of fenfluramine isomers in the rat | Q71083316 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 103-110 | |
| P577 | publication date | 1995-02-01 | |
| P1433 | published in | Neurochemistry International | Q7002160 |
| P1476 | title | Are interspecies comparisons in the toxicity of centrally acting drugs valid without brain concentrations? A commentary | |
| P478 | volume | 26 |
Search more.